CompletedPhase 4

Septorhinoplasty Post-operative Pain Control With SPG Nerve Block

United States50 participantsStarted 2023-04-12

Plain-language summary

Maxillary nerve blocks have been shown to significantly reduce post-operative pain and analgesic intake during the 24-hour period following sinus surgery. This randomized, double-blinded, placebo-controlled study will investigate blocks of the sphenopalatine ganglion using a suprazygomatic approach during septorhinoplasty surgery. It is the investigator's hypothesis that this technique will result in decreased post-operative pain and opioid use, and the morbidity associated with it.

Who can participate

Age range18 Years – 80 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patient presenting for open or endoscopic septorhinoplasty * Age 18-80 * Normal oral food and water intake before surgery * ASA physical classification 1-3 Exclusion Criteria: * Refusal to consent * Patients without a cellular phone or who are unable to accept text messages * Allergy to opioid narcotics * ASA physical classification of 4 or higher * Patient requires other surgery in addition to septorhinoplasty * Age \> 80 or \<18 * Any underlying chronic pain condition or ongoing opioid use over the preceding 3 months * Presence of any other factor which, at the discretion of any member of the study team, makes the patient a poor candidate for block placement. * Presence of any other factor which, at the discretion of any member of the study team, makes the patient a poor candidate for research participation. * Pregnant women

What they're measuring

Post Operative Pain Scores

Timeframe: 5 days +/- 2 days

Trial details

NCT IDNCT05667324

SponsorUniversity of Florida

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-02-28

Results submitted2026-02-23

View on ClinicalTrials.gov More Deviated Nasal Septum trials